Stocks and Investing Stocks and Investing
Wed, May 8, 2024
Tue, May 7, 2024

David Hoang Maintained (AXSM) at Strong Buy with Decreased Target to $125 on, May 7th, 2024


Published on 2024-10-28 11:04:50 - WOPRAI, David Hoang
  Print publication without navigation


David Hoang of Citigroup, Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy with Decreased Target from $127 to $125 on, May 7th, 2024.

David has made no other calls on AXSM in the last 4 months.



There are 8 other peers that have a rating on AXSM. Out of the 8 peers that are also analyzing AXSM, 0 agree with David's Rating of Hold.



These are the ratings of the 8 analyists that currently disagree with David


  • Vikram Purohit of "Morgan Stanley" Upgraded from Hold to Buy and Increased Target to $115 on, Monday, April 29th, 2024
  • Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $107 on, Wednesday, April 10th, 2024
  • Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Increased Target to $109 on, Thursday, March 28th, 2024
  • Joon Lee of "Truist Securities" Maintained at Strong Buy and Held Target at $150 on, Tuesday, March 26th, 2024
  • Leonid Timashev of "RBC Capital" Maintained at Buy with Increased Target to $128 on, Tuesday, March 26th, 2024
  • Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Increased Target to $125 on, Wednesday, February 21st, 2024
  • Ashwani Verma of "UBS" Initiated at Strong Buy and Held Target at $111 on, Tuesday, February 6th, 2024
  • David Amsellem of "Piper Sandler" Maintained at Buy with Increased Target to $113 on, Tuesday, January 16th, 2024
Contributing Sources